ArticlemAbs2017

Improved decision making for prioritizing tumor targeting antibodies in human xenografts: Utility of fluorescence imaging to verify tumor target expression, antibody binding and optimization of dosage and application schedule.

Michael Dobosz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.